A recent paper published in PLoS Biology reported the application of lipidomics in predicting the incidence of type 2 diabetes mellitus and cardiovascular diseases in a population cohort. The study demonstrates the role of lipidomics in prediction of diseases and translational research, which could herald the beginning of an era of quantitative lipidomics.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Han, X. & Gross, R. W. The foundations and development of lipidomics. J. Lipid Res. 63, 100164 (2022).
Yang, K. & Han, X. Lipidomics: Techniques, applications, and outcomes related to biomedical sciences. Trends Biochem. Sci. 41, 954–969 (2016).
Lauber, C. et al. Lipidomic risk scores are independent of polygenic risk scores and can predict incidence of diabetes and cardiovascular disease in a large population cohort. PLoS Biol. 20, e3001561 (2022).
Fernandez, C. et al. Plasma lipidome and prediction of type 2 diabetes in the population-based malmö diet and cancer cohort. Diabetes Care 43, 366–373 (2020).
Ottosson, F. et al. A plasma lipid signature predicts incident coronary artery disease. Int. J. Cardiol. 331, 249–254 (2021).
Surma, M. A. et al. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur. J. Lipid Sci. Technol. 117, 1540–1549 (2015).
Khan, S. R. et al. The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes. Diabetologia 62, 687–703 (2019).
Wang, M., Wang, C. & Han, X. Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why? Mass Spectrom. Rev. 36, 693–714 (2017).
Köfeler, H. C. et al. Quality control requirements for the correct annotation of lipidomics data. Nat. Commun. 12, 4771 (2021).
Köfeler, H. C. et al. Recommendations for good practice in MS-based lipidomics. J. Lipid Res. 62, 100138 (2021).
Acknowledgements
The author acknowledges the support of by National Institutes of Health P30 AG013319, P30 AG044271, P30 AG066546 (Biomarker Core), U19 AG069701, and U54 NS110435.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Han, X. The emerging role of lipidomics in prediction of diseases. Nat Rev Endocrinol 18, 335–336 (2022). https://doi.org/10.1038/s41574-022-00672-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-022-00672-9
This article is cited by
-
Diazobutanone-assisted isobaric labelling of phospholipids and sulfated glycolipids enables multiplexed quantitative lipidomics using tandem mass spectrometry
Nature Chemistry (2024)
-
Prioritize biologically relevant ions for data-independent acquisition (BRI-DIA) in LC–MS/MS-based lipidomics analysis
Metabolomics (2022)